메뉴 건너뛰기




Volumn 14, Issue 22, 2003, Pages 3569-3574

A pilot-scale synthesis of (1R)-trans-2-(2,3-dihydro-4-benzofuranyl) cyclopropanecarboxylic acid: A practical application of asymmetric cyclopropanation using a styrene as a limiting reagent

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,3 DIHYDRO 4 BENZOFURANYL)CYCLOPROPANECARBOXYLIC ACID; CYCLOPROPANECARBOXYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

EID: 0242541869     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetasy.2003.08.041     Document Type: Article
Times cited : (34)

References (16)
  • 1
    • 85030951435 scopus 로고    scopus 로고
    • Catt, J.; Johnson, G.; Keavy, D.; Mattson, R.; Parker, M.; Takaki, K.; Yevich, J. (Bristol-Myers Squibb) US 5981571, Nov 1999.
    • Catt, J.; Johnson, G.; Keavy, D.; Mattson, R.; Parker, M.; Takaki, K.; Yevich, J. (Bristol-Myers Squibb) US 5981571, Nov 1999.
  • 2
    • 85030945601 scopus 로고    scopus 로고
    • Some previous examples where olefin was used as a limiting reagent, see: (a) Doyle, M. P.; Van Leusen, D.; Tamblyn, W. H. Synthesis 1981, 787-789; (b) Majchrzak, M. W.; Kotelko, A. Synthesis 1983, 469-470.
    • Some previous examples where olefin was used as a limiting reagent, see: (a) Doyle, M. P.; Van Leusen, D.; Tamblyn, W. H. Synthesis 1981, 787-789; (b) Majchrzak, M. W.; Kotelko, A. Synthesis 1983, 469-470.
  • 3
    • 85030936277 scopus 로고    scopus 로고
    • Ellis, F.; Panchal, T.; North, P.; Cooke, J.; Smith, C. (Glaxo Wellcome) W00743272 A2 19971120.
    • Ellis, F.; Panchal, T.; North, P.; Cooke, J.; Smith, C. (Glaxo Wellcome) W00743272 A2 19971120.
  • 5
    • 85030952938 scopus 로고    scopus 로고
    • For recent reviews, see: (a) Pfalz, A.; Lydone, K.; McKervey, M. A.; Charette, A. B.; Leel, H. In Comprehensive Asymmetric Catalysis; Jacobsen E. N. ; Pfalz, A.; Yamamoto, H., Eds.; Springer, 1999; pp. 513-603; (b) Doyle, M. P.; Protopopova, M. Tetrahedron 1998, 54, 7919-7946; (c) Doyle, M. P.; Forbes, D. C. Chem. Rev. 1998, 98, 911-935.
    • For recent reviews, see: (a) Pfalz, A.; Lydone, K.; McKervey, M. A.; Charette, A. B.; Leel, H. In Comprehensive Asymmetric Catalysis; Jacobsen E. N. ; Pfalz, A.; Yamamoto, H., Eds.; Springer, 1999; pp. 513-603; (b) Doyle, M. P.; Protopopova, M. Tetrahedron 1998, 54, 7919-7946; (c) Doyle, M. P.; Forbes, D. C. Chem. Rev. 1998, 98, 911-935.
  • 9
    • 85030936059 scopus 로고    scopus 로고
    • 4-Vinyl-2,3-dihydrobenzofuran was prepared to according to the procedure described in Ref. 3. The authors would like to thank Dr. Meena Rao and Ms. Ming Yang for providing several laboratory scale batches of the vinyl- dihydrobenzofuran for the evaluation of the cyclopropanation.
    • 4-Vinyl-2,3-dihydrobenzofuran was prepared to according to the procedure described in Ref. 3. The authors would like to thank Dr. Meena Rao and Ms. Ming Yang for providing several laboratory scale batches of the vinyl- dihydrobenzofuran for the evaluation of the cyclopropanation.
  • 11
    • 85030946223 scopus 로고    scopus 로고
    • 4-1 consisting of 8 factorial points plus 4 center points to measure experimental error. This experiment was able to examine main effects on reaction completion, and confounded 2-way interactions between four factors such as concentration of olefin, equiv. of diazoacetate, concentration of diazoacetate and addition rate of diazoacetate.
    • 4-1 consisting of 8 factorial points plus 4 center points to measure experimental error. This experiment was able to examine main effects on reaction completion, and confounded 2-way interactions between four factors such as concentration of olefin, equiv. of diazoacetate, concentration of diazoacetate and addition rate of diazoacetate.
  • 12
    • 85030948378 scopus 로고    scopus 로고
    • Kotnis, A. S.; Simpson, J. H.; Deshpande, R. P.; Kacsur, D. J.; Hamm, J. ; Kodersha, G.; Merkl, W.; Domina, D.; Wang, S. S. Y. Org. Proc. Res. Develop., in press.
    • Kotnis, A. S.; Simpson, J. H.; Deshpande, R. P.; Kacsur, D. J.; Hamm, J. ; Kodersha, G.; Merkl, W.; Domina, D.; Wang, S. S. Y. Org. Proc. Res. Develop., in press.
  • 14
    • 85030936710 scopus 로고    scopus 로고
    • Initially, the diastereoselective crystallization using (+)-dehydroabeitylamine was developed by our colleague Dr. Brian Kaller for the resolution of racemic 2. During this development 26 homochiral amines under various solvent conditions were evaluated prior to selection of (+)-dehydroabeitylamine.
    • Initially, the diastereoselective crystallization using (+)-dehydroabeitylamine was developed by our colleague Dr. Brian Kaller for the resolution of racemic 2. During this development 26 homochiral amines under various solvent conditions were evaluated prior to selection of (+)-dehydroabeitylamine.
  • 15
    • 85030952287 scopus 로고    scopus 로고
    • In the pilot plant, the dehydroabeitylamine salt 5 was not dried due to dust hazards associated with it. Although the salt was found to be thermally stable, it was electrically non-conductive and was highly sensitive to electrical ignition. Therefore, after MTBE washes, the salt was washed with water, centrifuged and isolated as ca. 50 wt% water wet material. Authors would like to thank D. Domina and W. Merkl and Dr. S. Wang for providing safety assessment on the salt and the New Brunswick Pilot Plant staff for successful scale-up operations.
    • In the pilot plant, the dehydroabeitylamine salt 5 was not dried due to dust hazards associated with it. Although the salt was found to be thermally stable, it was electrically non-conductive and was highly sensitive to electrical ignition. Therefore, after MTBE washes, the salt was washed with water, centrifuged and isolated as ca. 50 wt% water wet material. Authors would like to thank D. Domina and W. Merkl and Dr. S. Wang for providing safety assessment on the salt and the New Brunswick Pilot Plant staff for successful scale-up operations.
  • 16
    • 85030944191 scopus 로고    scopus 로고
    • Takeda, N.; Ishii, S.; Sumitomo Chemicals Co.; Ltd. Patent JP48103514, 12/25/93. CA.: 80:132837.
    • Takeda, N.; Ishii, S.; Sumitomo Chemicals Co.; Ltd. Patent JP48103514, 12/25/93. CA.: 80:132837.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.